C5AR1 and amyotrophic lateral sclerosis: Complement inhibition was investigated in a study by Lee et al. (2017), who used PMX205 as a C5aR antagonist in hSOD1G93A mice which are a model of amyotrophic lateral sclerosis (ALS) [141].